Surgut State University
Surgut State University - a non-steroidal anti-inflammatory agent.
Surgut State University reduces inflammation and fever, has analgesic effect. The active ingredient of the drug Surgut State University - tiaprofenic acid.
Surgut State University released in the form of a powder for injections, rectal suppositories, tablets.
Surgut State University is prescribed for degenerative, inflammatory diseases of the musculoskeletal system: rheumatoid arthritis and gouty, ankylosing spondylitis.
Effectively relieves pain at Surgut State University tenosynovitis, myalgia, bursitis, neuralgia, arthralgia, headache, toothache, radiculitis, traumatic pain, burns, menstrual pain.
There is experience of successful application Surgama infectious diseases, colds - tiaprofenic acid helps relieve fever.
The tablets may be administered to adults two times a day - 300 mg; children after three years 10 mg / kg, 2-3 hours. Surgut State University is best to drink tablets during meals.
Rectal suppositories SurGu adults use twice a day 0, 3 g, children appoint 1st candle (0, 15 g) two or three times per day. The treatment lasts 3-5 days.
If severe pain can make an intramuscular injection Surgama. First inject 400 mg, thereafter - 200 mg every 8 hours for two days and another 200 mg of 4-6 days. After such a course of pills a patient is transferred to Surgut State University.
Side effects Surgama
Surgut State University can cause abdominal pain, diarrhea, vomiting, tachycardia, high blood pressure, dizziness, drowsiness, irritability, headache, depression, hearing loss, vision problems, cystitis, acute renal failure, dysuria, nephritis, leukopenia, thrombocytopenia, urticaria, photosensitivity skin, angioneurotic edema, tinnitus, bronchospasm, impaired liver function, increased sweating.
Prolonged use Surgama in large quantities can cause ulcers in the gastrointestinal mucosa, hemorrhoids, gastrointestinal, uterine, gingival bleeding.
Surgut State University is contraindicated in erosion of the gastrointestinal tract, chronic heart failure, edema, hypersensitivity to tiaprofenic acid, increased pressure, kidney or liver failure, hearing loss, anticoagulation, vestibular disease, hemophilia, deficiency of glucose-6-phosphate dehydrogenase, blood diseases, during lactation, pregnancy.
Precautions should be taken when SurGu hyperbilirubinemia.
In appointing Surgama patient warned of the possibility of reducing the concentration of attention.
It was found that the Surgut State University reduces the effectiveness of drugs that increase the excretion of uric acid, a diuretic, and such that the pressure is increased, increases the effect of antiplatelet agents, anticoagulants, fibrinolytic agents.